to evaluate the functional and structural measurements for glaucoma detection and monitoring at different stages of the disease.
ID
Source
Brief title
Condition
- Glaucoma and ocular hypertension
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Structural and functional measurements
Secondary outcome
See protocol
Background summary
The use of structural measurements from imaging devices and functional
measurements from perimetry for the detection and monitoring of glaucoma
remains a topic of great interest in current scientific research. There is no
consensus on what measurement technique or combination of techniques is best
used for the detection of glaucoma and the monitoring of the disease in the
early, moderate and advanced stages of glaucoma. This is partly because
comparing these different measurements techniques in the different stages of
glaucoma is difficult because they measure different quantities, expressed by
different units. Furthermore, there is sufficient evidence that the correlation
between structural and functional measurements is poor. This poor correlation
has several causes, such as measurement noise and differences in measurement
variability and bandwidth between the various measurements techniques in the
different stages of glaucoma. A comparison of the performance of each
measurement technique for the different stages of glaucoma would enable us to
select the optimal technique for both the detection and monitoring of glaucoma,
and thereby further improve our clinical management of glaucoma.
Study objective
to evaluate the functional and structural measurements for glaucoma detection
and monitoring at different stages of the disease.
Study design
Observational cross-sectional and longitudinal cohort-study
Study burden and risks
Imaging with commercially available low-luminance ophthalmic camera*s and
scanning devices, functional testing with standard perimetry (usual care),
measurements of intraocular pressure (usual care). Added burden will be 0.5-1.5
hour per annum for patients with glaucoma and 1.5-2.0 hours per annum for
healthy controls. No risks.
Schiedamse Vest 180
Rotterdam 3011 BH
NL
Schiedamse Vest 180
Rotterdam 3011 BH
NL
Listed location countries
Age
Inclusion criteria
Age >= 40 years and < 80 years
Informed consent
BCVA of 0.3 or better (LogMAR)
Refractive error between -10.0 to +5.0 D range
(See section 4.2 of the protocol).
Exclusion criteria
Ophthalmic:
Cataract surgery in previous 12 months
Previous refractive or vitreoretinal surgery.
Diabetic retinopathy, diabetic macular oedema, or other vitreo-retinal disease
Corneal defects
Previous keratoplastic surgery.
Systemic:
Diabetes, leukaemia, AIDS, uncontrolled hypertension, multiple sclerosis (MS) or life threatening disease.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL60260.078.16 |